RP2
RP2 activator of ARL3 GTPase
Basic information
Region (hg38): X:46837042-46882358
Links
Phenotypes
GenCC
Source:
- retinitis pigmentosa 2 (Strong), mode of inheritance: XL
- retinitis pigmentosa (Supportive), mode of inheritance: AD
- RP2-related retinopathy (Definitive), mode of inheritance: XL
Clinical Genomic Database
Source:
Condition | Inheritance | Intervention Categories | Intervention/Rationale | Manifestation Categories | References |
---|---|---|---|---|---|
Retinitis pigmentosa 2 | XL | General | Genetic knowledge may be beneficial related to issues such as selection of optimal supportive care, informed medical decision-making, prognostic considerations, and avoidance of unnecessary testing | Ophthalmologic | 9697692; 10053026; 10942419; 11462235; 12417528; 20021257; 20625056; 21738648 |
ClinVar
This is a list of variants' phenotypes submitted to
- not provided (227 variants)
- Retinitis pigmentosa (56 variants)
- Retinitis pigmentosa 2 (32 variants)
- Retinal dystrophy (21 variants)
- Retinitis pigmentosa 3 (10 variants)
- not specified (5 variants)
- Inborn genetic diseases (5 variants)
- Leber congenital amaurosis (3 variants)
- X-linked retinitis pigmentosa (2 variants)
- Macular dystrophy (1 variants)
- Abnormality of the eye (1 variants)
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the RP2 gene is commonly pathogenic or not.
Variant type | Pathogenic | Likely pathogenic | VUS | Likely benign | Benign | Sum |
---|---|---|---|---|---|---|
synonymous | 1 | 1 | 11 | 7 | 20 | |
missense | 3 | 6 | 92 | 12 | 12 | 125 |
nonsense | 26 | 4 | 30 | |||
start loss | 0 | |||||
frameshift | 54 | 9 | 63 | |||
inframe indel | 3 | 3 | 6 | |||
splice variant | 5 | 7 | 5 | 17 | ||
non coding | 1 | 2 | 5 | 4 | 12 | |
Total | 89 | 30 | 103 | 28 | 23 |
Variants in RP2
This is a list of pathogenic ClinVar variants found in the RP2 region.
Position | Type | Phenotype | Significance | ClinVar |
---|---|---|---|---|
X-46837057-G-C | Retinitis pigmentosa | Likely benign (Jan 13, 2018) | ||
X-46837066-A-G | Retinitis pigmentosa | Uncertain significance (Jan 13, 2018) | ||
X-46837075-G-T | Retinitis pigmentosa | Uncertain significance (Jan 12, 2018) | ||
X-46837089-CGGGCTGGGACCAT-C | Pathogenic (Dec 09, 2020) | |||
X-46837101-A-G | Pathogenic (Aug 09, 2022) | |||
X-46837101-A-T | Pathogenic (Feb 14, 2022) | |||
X-46837102-T-A | Pathogenic (Aug 28, 2021) | |||
X-46837102-T-C | Retinitis pigmentosa • X-linked retinitis pigmentosa | Pathogenic (Jul 12, 2022) | ||
X-46837102-T-G | Pathogenic (May 29, 2022) | |||
X-46837104-G-A | Uncertain significance (May 27, 2022) | |||
X-46837104-G-T | Uncertain significance (May 06, 2022) | |||
X-46837108-G-C | Retinitis pigmentosa 2 | Conflicting interpretations of pathogenicity (Nov 01, 2022) | ||
X-46837108-GCTT-G | Macular dystrophy • Retinal dystrophy • Cone-rod dystrophy | Conflicting interpretations of pathogenicity (Jul 24, 2023) | ||
X-46837111-T-G | Retinitis pigmentosa | Conflicting interpretations of pathogenicity (Jul 19, 2022) | ||
X-46837111-TC-AA | Pathogenic (Sep 24, 2021) | |||
X-46837114-TCTC-T | Retinitis pigmentosa 2 • Retinitis pigmentosa | Likely pathogenic (Jun 13, 2022) | ||
X-46837118-CAA-C | Pathogenic (Jul 19, 2022) | |||
X-46837119-A-C | Retinal dystrophy | Uncertain significance (Jul 28, 2021) | ||
X-46837122-A-T | Pathogenic (Aug 23, 2021) | |||
X-46837122-AGACG-A | Retinitis pigmentosa | Pathogenic (Jun 23, 2019) | ||
X-46837125-CGGAAGGCTGACAA-C | Pathogenic (Dec 18, 2021) | |||
X-46837128-A-G | Uncertain significance (Jun 30, 2021) | |||
X-46837130-G-A | Retinitis pigmentosa | Conflicting interpretations of pathogenicity (Nov 01, 2022) | ||
X-46837137-A-T | Retinal dystrophy | Likely pathogenic (Dec 31, 2018) | ||
X-46837138-A-T | Retinal dystrophy | Uncertain significance (Mar 27, 2019) |
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
RP2 | protein_coding | protein_coding | ENST00000218340 | 5 | 45419 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
0.956 | 0.0439 | 123595 | 0 | 1 | 123596 | 0.00000405 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | 0.633 | 112 | 133 | 0.845 | 0.00000987 | 2330 |
Missense in Polyphen | 10 | 29.608 | 0.33774 | 502 | ||
Synonymous | 0.932 | 40 | 48.2 | 0.829 | 0.00000361 | 650 |
Loss of Function | 2.90 | 0 | 9.79 | 0.00 | 6.92e-7 | 179 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.00 | 0.00 |
Ashkenazi Jewish | 0.00 | 0.00 |
East Asian | 0.00 | 0.00 |
Finnish | 0.00 | 0.00 |
European (Non-Finnish) | 0.00 | 0.00 |
Middle Eastern | 0.00 | 0.00 |
South Asian | 0.0000542 | 0.0000341 |
Other | 0.00 | 0.00 |
dbNSFP
Source:
- Function
- FUNCTION: Acts as a GTPase-activating protein (GAP) involved in trafficking between the Golgi and the ciliary membrane. Involved in localization of proteins, such as NPHP3, to the cilium membrane by inducing hydrolysis of GTP ARL3, leading to the release of UNC119 (or UNC119B). Acts as a GTPase-activating protein (GAP) for tubulin in concert with tubulin-specific chaperone C, but does not enhance tubulin heterodimerization. Acts as guanine nucleotide dissociation inhibitor towards ADP-ribosylation factor-like proteins. {ECO:0000269|PubMed:11847227, ECO:0000269|PubMed:18376416, ECO:0000269|PubMed:20106869, ECO:0000269|PubMed:22085962}.;
- Disease
- DISEASE: Retinitis pigmentosa 2 (RP2) [MIM:312600]: A retinal dystrophy belonging to the group of pigmentary retinopathies. Retinitis pigmentosa is characterized by retinal pigment deposits visible on fundus examination and primary loss of rod photoreceptor cells followed by secondary loss of cone photoreceptors. Patients typically have night vision blindness and loss of midperipheral visual field. As their condition progresses, they lose their far peripheral visual field and eventually central vision as well. {ECO:0000269|PubMed:10090907, ECO:0000269|PubMed:10520237, ECO:0000269|PubMed:10634633, ECO:0000269|PubMed:10937588, ECO:0000269|PubMed:10942419, ECO:0000269|PubMed:11462235, ECO:0000269|PubMed:11847227, ECO:0000269|PubMed:11992260, ECO:0000269|PubMed:12657579, ECO:0000269|PubMed:14564670, ECO:0000269|PubMed:16472755, ECO:0000269|PubMed:22334370, ECO:0000269|PubMed:9697692}. Note=The disease is caused by mutations affecting the gene represented in this entry.;
- Pathway
- Trafficking of myristoylated proteins to the cilium;Cargo trafficking to the periciliary membrane;Cilium Assembly;Organelle biogenesis and maintenance
(Consensus)
Recessive Scores
- pRec
- 0.288
Intolerance Scores
- loftool
- 0.122
- rvis_EVS
- 0.35
- rvis_percentile_EVS
- 74.18
Haploinsufficiency Scores
- pHI
- 0.156
- hipred
- Y
- hipred_score
- 0.547
- ghis
- 0.522
Essentials
- essential_gene_CRISPR
- N
- essential_gene_CRISPR2
- N
- essential_gene_gene_trap
- N
- gene_indispensability_pred
- E
- gene_indispensability_score
- 0.569
Gene Damage Prediction
All | Recessive | Dominant | |
---|---|---|---|
Mendelian | Medium | Medium | Medium |
Primary Immunodeficiency | Medium | Medium | Medium |
Cancer | Medium | Medium | Medium |
Mouse Genome Informatics
- Gene name
- Rp2
- Phenotype
- nervous system phenotype (the observable morphological and physiological characteristics of the extensive, intricate network of electochemical structures in the body that is comprised of the brain, spinal cord, nerves, ganglia and parts of the receptor organs that are manifested through development and lifespan); vision/eye phenotype;
Zebrafish Information Network
- Gene name
- rp2
- Affected structure
- retinal rod cell
- Phenotype tag
- abnormal
- Phenotype quality
- degeneration
Gene ontology
- Biological process
- cell morphogenesis;protein folding;post-Golgi vesicle-mediated transport;post-chaperonin tubulin folding pathway;visual perception;protein transport;positive regulation of GTPase activity
- Cellular component
- nucleoplasm;cytoplasm;Golgi apparatus;centriole;plasma membrane;cilium;nuclear body;cytoplasmic vesicle;ciliary basal body;extracellular exosome;periciliary membrane compartment
- Molecular function
- magnesium ion binding;GTPase activator activity;protein binding;GTP binding;unfolded protein binding